The heterotypic interactions of endothelial cells and mural cells (smooth muscle cells or pericytes) are crucial for assembly, maturation, and subsequent function of blood vessels. Yet, the molecular mechanisms underlying their association have not been fully defined.
B lood vessel formation is a dynamic and complex process that serves a vital role in both health and disease. At the onset of blood vessel formation, endothelial cells coalesce into tube-like structures, which become stabilized by the recruitment of mural cells such as pericytes and vascular smooth muscle cells (VSMCs) that encase the nascent vessel. 1, 2 A host of reports have implied that endothelial cells and mural cells are closely associated, and the interactions between them are required for the regulation of vessel formation, stabilization, remodeling and function in vivo and in vitro. [2] [3] [4] However, the way in which endothelial and mural cells communicate with each other remains poorly understood. Several different ligand-receptor systems have been implicated in heterotypic cell interactions to regulate the development and maintenance of the vasculature. Endothelial cell-secreted platelet-derived growth factor-B is known to be necessary for the recruitment of pericytes to newly formed vessels through platelet-derived growth factor receptor-␤. [5] [6] [7] Angiopoietin (Ang)-1 and Tie2 signaling has been shown to be critical for vessel maturation and stabilization, 3, 8 whereas the differentiation of VSMCs surrounding blood vessels depends on endothelial-derived transforming growth factor-␤. 3, 9 In addition to these signaling mediators, it is believed that additional receptor-ligand pairs regulate vascular cellcell communication. For example, High et al demonstrated that Notch signaling between endothelial cells and VSMCs governs smooth muscle differentiation. 10 Notch genes encode cell surface receptors that transduce signals between neighboring cells to regulate developmental processes such as cell fate decisions. 11, 12 Mammals express 4 Notch receptors (Notch1 to 4) and 5 membrane-bound ligands (Jagged [Jag]1, Jag2, Delta-like [Dll]1, Dll3, and Dll4). After binding, Notch receptors undergo proteolytic cleavages by tumor necrosis factor-␤-converting enzyme and the ␥-secretase complex to release the Notch intracellular domain (NICD). NICD then translocates to the nucleus, where it binds with the transcription factor CSL (CBF-1/RBP-Jk, Su[H], and Lag-1) and coactivator Mastermind-like (MAML) to trigger downstream gene expression. In the vasculature, alterations in Notch signaling result in abnormalities in vessel patterning and maturation. [13] [14] [15] In fact, recent findings of several research groups revealed a vital role for endothelialdependent Notch signaling in tip cell formation and sprouting. 16 -18 Yet, it is unclear to what extent Notch-regulated vascular patterning events are consequences of homotypic or heterotypic signaling.
In contrast to Notch1, which is widely expressed, 19 Notch3 is exclusively expressed in mural cells in the vasculature. 20 -24 In humans, Notch3 gene mutations give rise to CADASIL, an inherited early stroke syndrome leading to dementia caused by systemic vascular degeneration and eventual loss of VSMCs within the arterial wall. 25 In the mouse, genetic studies have implicated Notch3 in the regulation of smooth muscle maturation, modulation of vascular physiology, and response to ischemia. 26 -28 Although these studies shed light on the importance of Notch3 in blood vessel structure and function, they did not investigate the direct role of Notch3 in governing blood vessel formation. In this study, we explored the contribution of Notch3 in developmental and pathological angiogenesis using the mouse retina as a model. Our findings imply that Notch3 facilitates heterotypic interaction between endothelial and mural cells that in turn dictates blood vessel patterning. Furthermore, Notch3 appears to play a role in response to hypoxia by regulating the expression of Ang-2.
Methods

Animals
Notch3 Ϫ/Ϫ mice were a generous gift from Dr Tom Gridley. 29 Notch3 Ϫ/Ϫ , Notch3 ϩ/Ϫ , and wild-type littermates were obtained by crossing Notch3 ϩ/Ϫ and Notch3 ϩ/Ϫ mice. All experimental procedures on mice were performed according to the NIH Guide for the Care and Use of Laboratory Animals and were approved by the Institutional Committee for the Use of Animals in Research.
Cell Culture
Human aortic smooth muscle cells from Lonza were grown in DMEM supplemented with 10% FBS, 100 IU/mL penicillin-streptomycin. Cells between passages 6 and 8 were used for experiments. Mouse aortic smooth muscle cells were isolated from aortas of Notch3 ϩ/Ϫ and Notch3 Ϫ/Ϫ mice. Cells between passages 3 and 8 were used for experiments. Lentiviral and adenoviral transduction was performed as described previously. 30, 31 
Immunostaining on Whole-Mount Retinas
The immunostaining in retinas was performed as described previously. 30 Briefly, eyes were isolated from Notch3 Ϫ/Ϫ and Notch3 ϩ/Ϫ mice at indicated time points and fixed in 4% paraformaldehyde for 30 minutes. The cornea, sclera, lens, vitreous, and hyaloid vessels were removed to isolate retinas and radial incisions were made at equal intervals along the retinal edge. Subsequently, retinas were placed in cold methanol for 20 minutes, blocked, and permeabilized in PBS containing 5% donkey serum and 0.3% Triton X-100 for 1 hour. Primary antibody, Notch3 (1:100) (Santa Cruz Biotechnology), smooth muscle (SM) ␣-actin (1:1000) (Sigma), NG2 (1:200) (Millipore), or Ang-2 (1:200) (Zymed), collagen IV (1:200) (Millipore), or phospho-histone H3 (1:200) (Millipore) was costained with 10 g/mL TRITC-labeled isolectin B4 (Griffonia simplicifolia) (Invitrogen). Retinas were flat-mounted in Vectashield (Vector Laboratories). Confocal images were captured and vessels were quantified with NIH ImageJ software by a blind observer.
Cell Death Detection ELISA
For the detection of apoptosis, a cell death detection ELISA PLUS kit (Roche) was used. Isolated retinas were homogenized in 100 L of lysis buffer, and 20 L of the supernatant of each retina was assayed. For cells, aortic smooth muscle cells were serum-starved in DMEM with 0.25% FBS. An equal number of cells were used for cell death detection.
Aortic Ring Assay
Aortic-sprouting assays were performed as described previously with modification. 32 Briefly, aortas from Notch3 ϩ/Ϫ and Notch3 Ϫ/Ϫ littermates at postnatal day (P)11 were dissected, cut into 1-mmthick rings, and incubated overnight in complete EBM-2 media (Lonza) containing 10% FBS before being placed into a rat tail collagen gel (1.5 mg/mL). Forty-eight hours after embedding, rings were stained with 10 g/mL TRITC-labeled isolectin B4 and NG2 and imaged by confocal microscopy. Vessels were quantified with ImageJ software.
Oxygen-Induced Retinopathy
Oxygen-induced retinopathy (OIR) was induced as described previously, with minor modifications. 33 In brief, at P7, pups, along with nursing mothers, were placed in 70% oxygen. At P12, they were returned to 21% oxygen for 5 days. From P12 to P17, the animals were anesthetized, their retinas were collected, and isolectin B4 immunostaining on whole-mount retinas was performed. Avascular area was quantified as a percentage of whole retinal area. Neovascularization was quantified using ImageJ software by calculating the area of isolectin B4 staining of neovascular tufts as reported. 34 
RNA Isolation and Quantitative RT-PCR
Total RNA was extracted from mouse retinas using RNAqueous-4PCR kit (Invitrogen) and reverse-transcribed with M-MLV reverse transcriptase (Invitrogen) to generate cDNA. Quantitative PCR was performed using a StepOne PCR system (Applied Biosystems) with Power SYBR Green.
Statistical Analysis
Data analyses were performed using PrismGraph, and comparisons between data sets were made using Student's t test. Differences were considered significant if PϽ0.05, and data are presented as meansϮSEM. Data shown are representative of at least 3 independent experiments.
Results
Notch3 Protein Is Expressed in Retinal Mural Cells
Using an in vitro angiogenesis assay, we demonstrated recently that Notch3 mediates mural cell-enhanced blood vessel formation. 30 From these studies, we predicted that Notch3 would have a similar effect in vivo and would act to modulate blood vessel formation in a mural cell-dependent fashion. To address this premise, we examined angiogenesis in retinas of mice deficient for Notch3. Earlier reports had shown that Notch3 mRNA is expressed in the retinal vasculature and appeared localized to mural cells. 35 We confirmed expression of Notch3 protein in the retinal blood vessels by immunostaining. Whole-mount retinas stained with a Notch3 antibody in conjunction with endothelial-specific isolectin B4 demonstrated that Notch3 protein is specifically expressed in mural cells and is absent from endothelial cells within the retinal vascular network ( Figure 1A ). Furthermore, Notch3 protein is observed in mural cells at the angiogenic front, where endothelial sprouting activity is abundant ( Figure 1B ).
Non-standard Abbreviations and Acronyms
Notch3 Deletion Influences Development of the Retinal Vasculature
Notch3-null mice were previously shown to be viable and fertile, but adult mice exhibit structural defects in the distal arteries, including enlargement of the vessels and defective smooth muscle maturation. 28 To determine whether the expression of Notch3 in retinal mural cells regulates the process of blood vessel formation, we performed whole-mount isolectin B4 staining of mouse retinas and evaluated the pattern of the vasculature from Notch3 Ϫ/Ϫ , Notch3 ϩ/Ϫ , and wild-type littermates at different developmental stages. Retinal vessels begin to sprout from the optic disc right after birth and extend out to the periphery at P8. At P3, we found that retinas from Notch3 Ϫ/Ϫ mice displayed diminished vascularization. Coverage of the superficial retinal plexus was decreased by 30% in Notch3 Ϫ/Ϫ mice compared with Notch3 ϩ/Ϫ and Notch3 ϩ/ϩ retinas (Figure 2A and 2C). Examination of vessel patterning revealed a 30% reduction in vessel branch points ( Figure 2B and 2D), leading to an overall decline in vascular density. No difference was apparent in comparison of Notch3 heterozygote and wild-type animals. At P5 and P7, similar defects were observed in Notch3-null retinas, albeit to a lesser extent (Online Figure I , available in the Online Data Supplement at http://circres.ahajournals.org). Formation of the deep capillary network at the P10 and P14 stages revealed similar Notch3-dependent defects (Online Figure I ). In adult mice (P43), the vascular patterning defects associated with the absence of Notch3 were only slight (data not shown). These findings indicate that Notch3 acts as a regulator of vessel formation in vivo and may have a more pronounced role in early angiogenesis. The blood vessel-forming phenotype in Notch3-null retinas indicated a defect in vessel sprouting, which resulted in an overall decrease in vascular density. To determine whether the angiogenic defects observed in the Notch3-null mice might be caused by an absence of mural cells at the angiogenic front, we performed colocalization studies with isolectin B4 and the mural cell marker NG2. 36 These results showed that the mural cells in the Notch3-null retinas were normally distributed and appeared to associate with the developing vessels in a similar fashion to wild-type and heterozygous littermates (Online Figure  II) . Furthermore, to exclude the possibility that reduced vessel density was a result of increased vessel regression, we stained for collagen IV to detect empty collagen sleeves. 37 We observed no differences between the Notch3-null mice and controls (Online Figure III) . To directly evaluate the influence of Notch3 on vessel sprouting, we preformed ex vivo sprouting assays with isolated aortic rings. Thoracic aortas from Notch3-null mice exhibited reduced vessel sprouts when cultured for 2 days compared with heterozygous controls, whereas mural cell recruitment was not affected (Figure 3 ). Taken together, these results demonstrate that mural cellexpressed Notch3 can regulate vessel sprouting, not only in developing retinal capillaries but also in large elastic arteries prompted to undergo angiogenesis.
Notch3 Deletion Impairs the Investment of Mural Cells
Given that prior analysis of Notch3-deficient mice uncovered defects in smooth muscle maturation, 28 we sought to investigate how pericytes and smooth muscle cells of the retina were invested in the vascular network in the absence of Notch3. To do so, we undertook SM ␣-actin and NG2 staining to highlight retinal pericytes and smooth muscle cells, in conjunction with isolectin B4. In early developmental stages, mural cells appeared to be normally distributed in the vascular plexus of Notch3 Ϫ/Ϫ mice (Online Figure II) . However, the null animals showed significant reduction in SM ␣-actin staining at P8 and P15 ( Figure 4 ). Additionally, at P15, it was evident that the density of surrounding mural cells in arteries was dramatically decreased in Notch3 Ϫ/Ϫ mice, with the formation of visible gaps between adjacent cells ( Figure 4 ). The decrease in SM ␣-actin staining was even more pronounced in P43 adults, where mural cells were found sparsely surrounding the arteries (Figure 4 and Online Figure  IV) . These results indicate that the absence of Notch3 progressively impacts the investment of pericytes and smooth muscle cells over time. Because Notch3 is known to affect smooth muscle differentiation and particularly the expression of SM ␣-actin, 28 we used an additional mural cell marker, NG2 to highlight these cells. Consistent with the expression of SM ␣-actin, we observed a similar pattern of NG2 staining in null mice ( Figure 5A ). Thus, these findings show that the lack of SM ␣-actin staining was not attributable to an absence of marker expression but, rather, was caused by the progres- sive loss of mural cells. To further verify the absence of pericyte and smooth muscle cell coverage in adult retinas lacking Notch3, we costained with DAPI to mark nuclei within individual blood vessels. As predicted, the Notch3null vessels had an average of 58% fewer mural cell nuclei compared with wild-type and heterozygous littermates (Figure 5B and Online Figure IV) . We reasoned that the loss of mural cells from the retina had to occur by 1 of 2 processes: by mural cells becoming disassociated from the vessels and migrating away 7, 38 or by apoptosis. From careful analysis, we did not observe migrating mural cells in retinas of Notch3-null mice. Cells that remained were closely attached to the endothelial abluminal surface as in control retinas (H.L., B.L., unpublished observation, 2009). Prior evidence linking Notch3 to cell survival led us to pursue apoptosis as a mechanism for cell loss in the retinas. 39, 40 Apoptosis was assessed by a cell death ELISA kit using whole retinas from mice at P10. We observed that Notch3 Ϫ/Ϫ mice exhibited a statistically significant increase in apoptosis ( Figure 6A ). Assessment of proliferation in the Notch3-null and control retinas did not reveal any obvious differences (Online Figure V) . Although the difference in apoptosis was small, the progressive loss of mural cells suggests that Notch3 acts to suppress cell death, and, in its absence over time, cells gradually succumb, resulting in considerable deficiency of mural cells. To further confirm this, we performed in vitro apoptosis assays using mouse aortic smooth muscle cells isolated from heterozygous and homozygous animals. Consistent with our in vivo data, Notch3-deficient smooth muscle cells exhibited an increase in apoptosis compared with control cells ( Figure 6B ).
Notch3 Modulates Pathological Angiogenesis
To investigate the role of Notch3 in pathological angiogenesis, we used a mouse model of OIR. 33 In this model, P7 pups were exposed to 70% oxygen (hyperoxia) for 5 days (P7 to P12) to induce vascular regression and obliteration in the central retina. At P12, mice were returned to room air for 5 days, during which time period, relative hypoxia initiates rapid vessel growth and pathological neovascularization. We examined the vascular phenotypes of mice subjected to OIR. At the height of vascular regression in P12 retinas, Notch3 Ϫ/Ϫ mice and Notch3 ϩ/Ϫ littermates had a comparable vascular obliteration, which quantitatively occupied Ϸ35% of the total retinal surface (Online Figure VI) . These data show that Notch3 deficiency does not affect the susceptibility of retinal vasculature to oxygen-induced vessel regression. In contrast, during the neovascularization phase, Notch3 Ϫ/Ϫ retinas exhibited a diminished number of new blood vessels, compared with Notch3 ϩ/Ϫ littermates ( Figure 7A through 7C ). In the null mice, there was a 35% decrease in neovascularization. Moreover, the number and the size of vascular tufts were reduced in Notch3 Ϫ/Ϫ animals. To characterize the vascular tufts in more detail, retinas were costained for isolectin B4 and NG2. 41 These images revealed that NG2-positive staining was seen in both the heterozygous and null tufts at similar intensities ( Figure 7D ). Thus, under pathological conditions, Notch3 deletion has a negligible effect on vascular regression but substantially impairs the process of neovascularization, as evidenced by a decrease in the size and number of vascular tufts.
Notch3 Expression Is Increased During Oxygen-Induced Neovascularization and Regulates Angiopoietin-2
To further explore the role of Notch3 in retinal neovascularization, we examined its expression in retinas of wild-type mice subjected to OIR. Compared with mice in normoxia, Notch3 mRNA was increased in relative hypoxia, as assessed by quantitative PCR (Figure 8A ). At P12, just after hyperoxia treatment, Notch3 expression was slightly lower than that of normoxia controls, probably because of an overall decrease in blood vessels. However, by P15, Notch3 mRNA surpassed control levels and at P17 exceeded control expression by more than 2-fold. These observations signify that Notch3 might have a unique role in modulating vascular development under pathological conditions. It is known that pathological angiogenesis is stimulated by an increase in angiogenic factors such as vascular endothelial growth factor (VEGF) and the angiopoietins. 42 Given that Notch proteins function as transcription coactivators, and Notch3 is increased in hypoxia, we theorized that it might act to regulate the expression of certain other factors during hypoxia. Examination of known Notch target genes 43 in hypoxia-treated retinas at P17 revealed a significant decrease in Hrt3 mRNA expression in Notch3-null mice (Online Figure VII) . We next evaluated mRNA levels of angiogenic growth factors and their receptors in these same hypoxiatreated retinas. Expression of VEGF-A, VEGF-C, Ang-1, and Tie-2 all exhibited similar expression levels in Notch3 ϩ/Ϫ and Notch3 Ϫ/Ϫ littermates (Online Figure VII) . Conversely, Ang-2 mRNA expression was decreased by approximately 40% in the null retinas compared with control ( Figure 8B ). The expression of Ang-2 was additionally assessed by immunostaining, which showed the Ang-2 protein was significantly reduced in Notch3 deficient mice ( Figure 8C ). In the retina, Ang-2 expression is upregulated during both physiological and pathological neovascularization (Online Figure  VIII and elsewhere 44 ). Mice that are deficient for Ang-2 exhibit reduced hypoxia-driven angiogenesis, 45, 46 similar to that observed in our Notch3-null animals. These combined results suggest that one mechanism in which Notch3 governs pathological angiogenesis is by regulation of Ang-2. To evaluate whether the Notch3-dependent reduction in Ang-2 is unique to the pathological conditions produced by hypoxia, we examined the expression of Ang-2 in Notch3-null and heterozygous mice under normoxia. In P17 retinas isolated from mice exposed to room air, the Notch3 deletion had no effect on Ang-2, Ang-1, or Tie-2 expression, or that of Hes1, Hrt2, and Hrt3 (Online Figure IX) . These experiments imply that Ang-2 is a target of Notch3 only during oxygen-induced neovascularization and suggest that crosstalk between Notch3 and hypoxic signaling triggers this distinct expression.
To determine whether Notch3 could directly induce Ang-2 expression, we overexpressed a constitutively active form of Notch3 (NICD3) and measured Ang-2 mRNA. Lentiviral transduction of the NICD3 in primary cultures of human aortic smooth muscle cells caused Ang-2 mRNA expression to be significantly increased compared with control cells transduced with a GFP-expressing lentivirus ( Figure 8D ). Hypoxiainducible factor (HIF)1␣ is a key regulator of hypoxia-induced signaling, and was previously shown to directly interact with Notch1 to activate transcription. 42, 47 To determine whether HIF1␣ and Notch3 cooperate to regulate the expression of Ang-2, we cotransduced the NICD3 with a HIF1␣ cDNA and measured Ang-2 transcript levels. Indeed, whereas Ang-2 expression was augmented by NICD3, addition of HIF1␣ with NICD3 produced a greater increase in Ang-2 ( Figure  8D ). Interestingly, HIF1␣ transduction in aortic smooth muscle cells did not invoke an increase in Ang-2 expression on its own and required the NICD3. Thus, as suggested by previous reports, 48, 49 the regulation of Ang-2 expression in mural cells differs from that in endothelial cells and likely depends on Notch3 in hypoxia. Overall, these results indicate that Ang-2 is a direct target of Notch3 in mural cells, and Notch3 specifically regulates its expression under pathological conditions, possibly in conjunction with HIF1␣. In summary, our data support the notion that Notch3 modulates oxygen-induced neovascularization by regulating the expression of Ang-2 from mural cells, which then acts on adjacent Tie-2-expressing endothelial cells to modulate blood vessel assembly.
Discussion
Notch signaling can regulate cell-to-cell communication and control cell fate decisions in a variety of cell types. In the vascular endothelium, signaling between Dll4 and Notch1 in tip and stalk cells, respectively, prevents stalk cell sprouting. 16 This Notch-dependent homotypic interaction helps to pattern blood vessels. In this study, we asked how Notch signaling might facilitate heterotypic interactions between mural cells and endothelial cells that help shape the vasculature. Previous work has suggested an important role for pericytes in modulating tube formation, 50, 51 and an in vitro study by our laboratory demonstrated that mural cell-expressed Notch3 affects angiogenesis. 30 Here, we show that under physiological conditions, Notch3 deletion decreases vascularization in the mouse retina at early developmental stages. These angiogenic defects are not a result of enhanced regression, which points to growth retardation as the likely cause. The decline in angiogenesis is associated with a reduction in branching, and accordingly, these data reveal that Notch activity in mural cells can modulate vascular patterning. Our results show that in the absence of Notch3, mural cells are still present at leading edge of growing vessels. Thus, the observed angiogenic defects must be attributable to improper signaling from these cells. The way in which Notch3 receptor signaling from mural cells instructs endothelial cells is not entirely clear. However, previous studies have offered insight into a potential mechanism. One study showed that an endothelial-specific knockout of Jagged1 has reduced retinal angiogenesis, including branching defects 52 that resemble those we observed in Notch3deficient mice. Another demonstrated that mice lacking endothelial-expressed Jagged1 have severe mural cell defects. 10 In addition, previous data from our laboratory showed that Jagged1 on endothelial cells promotes Notch activity and mural cell differentiation. 30 In light of these previously published findings, one possible model to explain the Notch3-dependent angiogenic phenotype is that endothelial-expressed Jagged1 signals to Notch3 on mural cells to promote mural cell investment. The invested mural cells then influence endothelial growth and branching by producing secreted factors. Indeed, additional studies will be required to elucidate the exact mechanism through which Notch3 influences vessel patterning.
Adult Notch3-null mice exhibit impaired arterial differentiation, enlargement of vessels, and defective maturation of VSMCs. 28 In addition, Notch3 deficiency impacts vascular tone in resistance arteries, indicative of functional defects in smooth muscle cells. 27 To investigate more thoroughly the vascular smooth muscle defects associated with loss of Notch3, we examined them in the retinal vasculature. This vascular bed is formed postnatally and is conducive to stepwise analysis of mural cell recruitment and differentiation. From our experiments, mural cells initially appeared to be recruited normally in Notch3-null mice, albeit the expression of SM ␣-actin was slightly decreased. However, over time, mural cells surrounding the vessels were progressively lost. Apoptosis assays revealed a small but significant increase in cell death, consistent with previous reports that linked Notch3 to cell viability. 39, 40 These results are in contrast to those published by Domenga et al, who reported no detectable apoptosis in the tail arteries of Notch3 Ϫ/Ϫ adult mice. 28 This discrepancy could be attributable to differences in the vascular beds that were analyzed. Yet, in vitro apoptosis assays that we performed on aortic smooth muscle cells from Notch3 heterozygous and null mice were consistent with our in vivo results from retinal tissue. We believe that in the absence of Notch3, the small increase in apoptosis leads to an incremental loss of mural cells over time. Thus, Notch3 not only functions to regulate arterial differentiation and maturation 28 but also controls the investment and stability of mural cells contributing to functional blood vessels.
Our data indicate that the loss of pericytes has little effect on retinal angiogenesis, because mural cells begin to be lost after P8 in Notch3-null mice; yet, the angiogenic phenotypes we observed were most pronounced before this stage. The loss of Notch3 appears to have no effect on recruitment. Our data show that mural cells are present and distributed normally at the angiogenic front. These would imply that it is not the absence of Notch3-deficient mural cells that affects vessel growth but a defect in their function. Currently, we do not know the exact mechanism through which Notch3 conveys angiogenic signals. Possibilities include heterotypic signaling to endothelial cells or Notch-regulated gene expression of angiogenic factors in mural cells. At later stages after the vessels are formed, mural cell loss does not seriously impact their stability or regression. We did observe an overall enlargement of arteries in Notch3-deficient retinas at later stages (data not shown), similar to the findings in the study by Domenga et al. 28 Taken together, these findings imply that pericyte-expressed Notch3 impinges on endothelial cell vessel-forming capabilities early on to regulate assembly, and once the vessel network is established, mural cells have little effect on modulating blood vessel structure. Importantly, however, we cannot exclude the possibility that compensatory mechanisms are activated in the null mice, which mask additional roles of Notch3 in mural cells. Perhaps other Notch receptors, such as Notch1, take over in the absence of Notch3.
Notch3 function has been linked to ischemic diseases. Arboleda-Velasquez et al showed that Notch3-deficient mice were more susceptible to ischemic stroke, 26 whereas Li et al revealed a protective effect of Notch3 deficiency for the development of pulmonary hypertension. 53 In the present study, using an ischemia-induced retinopathy model, we demonstrate that Notch3 plays a direct role in proliferative neovascularization. In the absence of Notch3, vascular tufts are decreased, suggesting that in ischemia, Notch3 acts to promote blood vessel formation, possibly as a maladaptive response to hypoxia. Similar to physiological conditions, Notch3 does not appear to be required for recruitment of mural cells in hypoxic conditions. Our experiments did not address whether Notch3 is required for mural cell stability and investment in this disease state, as it is during development. The Notch pathway is known to intersect with hypoxic signaling, and Notch1 and HIF1␣ can directly interact to regulate transcription. 47, 54 Consequently, it is not surprising that Notch3 affects blood vessel formation in disease states, although the transcriptional targets of Notch signaling in ischemia have not been described previously. Here, our results show for the first time that Ang-2 is a target of Notch3 under ischemic conditions. Moreover, we show that Notch3 cooperates with HIF1␣ to regulate Ang-2. Indicative of a mutual pathway, Ang-2-deficient mice share phenotypic similarities with Notch3-null mice subjected to OIR. 45, 46 Therefore, the convergence of Notch3 and HIF1␣ onto Ang-2 likely serves to precisely control this vital signaling factor exclusively in ischemia.
In summary, our data conclusively show that mural cellexpressed Notch3 is important for modulating distinct aspects of developmental and pathological blood vessel formation. Notch3 signaling to endothelial cells regulates vessel branching, and its expression on mural cells is critical for their differentiation and viability. Furthermore, in pathological conditions, Notch3 regulates Ang-2 expression under hypoxia, demonstrating a role for this Notch family member in governing neovascularization. Our results suggest that Notch3 uses multiple mechanisms to control different aspects of blood vessel formation and function, and they differ under normal and aberrant states. Thus, therapeutic targeting of Notch3 might be a novel approach for disrupting angiogenesis in certain vascular-related diseases.
